Skip to main content

News

Over £34k raised by #TeamCardiff runners at Cardiff Half Marathon

7 October 2024

Over 100 alumni, students, and staff ran the Principality Cardiff Half Marathon to raise funds for Cardiff University research.

Bacteria triggers type-1 diabetes

18 September 2024

Bacterial infection can induce an immune response that leads to type-1 diabetes, according to Cardiff University researchers.

BioFAIR is ready to transform data management in life sciences research

5 August 2024

Academics from Systems Immunity Research Institute and the Digital Transformation Innovation Institute are supporting a new project that seeks to democratise access to life sciences data, workflow and communities.

Psoriasis drug shows promise for treating childhood diabetes

30 July 2024

A drug commonly used to treat psoriasis, Ustekinumab, has been found to be effective in helping to treat children and adolescents with type-1 diabetes.

£1 million funding for cancer research studentships

29 January 2024

Nine PhDs to be supported thanks to largest gift to date from Myristica Trust.

Over £27k raised by #TeamCardiff Cardiff Half runners

11 October 2023

On Sunday 1 October, over 100 alumni, students, and staff ran the Principality Cardiff Half Marathon as part of the University’s #TeamCardiff.

Superior T-cell discovered in cancer survivors

24 July 2023

Multipronged T-cells discovered which “might be associated with complete cancer remission” say Cardiff team

Systems Immunity Research Institute showcases recent successes

5 July 2023

Cardiff University’s research into harnessing and understanding the immune system is ensuring global public health.

Blood differences in long COVID patients

5 April 2023

New research finds differences in immune responses in patients with long Covid

Global focus for Cardiff University’s innovation and research institutes

23 March 2023

Cardiff University has launched five innovation and research institutes dedicated to tackling some of the biggest challenges facing our world.